Post-approval studies (Phase 4)Study completedNCT00954122What this trial is testingEfficacy and Safety of SEROQUEL Extended Release (XR) in Acute SchizophreniaWho this might be right forSchizophrenia AstraZeneca 35
Large-scale testing (Phase 3)Study completedNCT00136994What this trial is testingIM and Oral in Acute Exacerbation of Schizophrenia (BIZET Study)Who this might be right forSchizophrenia Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 160
Large-scale testing (Phase 3)UnknownNCT05803642What this trial is testingOlanzapine in Patients With Acute AgitationWho this might be right forAcute Agitation Qilu Pharmaceutical Co., Ltd. 318
Large-scale testing (Phase 3)Study completedNCT00628589What this trial is testingStaccato Loxapine in Agitated Patients With SchizophreniaWho this might be right forPatients With Schizophrenia and Acute Agitation Alexza Pharmaceuticals, Inc. 344
Post-approval studies (Phase 4)Study completedNCT01400113What this trial is testingTreating Acutely Agitated Patients With Asenapine Sublingual TabletsWho this might be right forAgitation Unity Health Toronto 120
Post-approval studies (Phase 4)UnknownNCT00838032What this trial is testingPilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With SchizophreniaWho this might be right forAcute Schizophrenia Sichuan University 70
Not applicableStudy completedNCT00631722What this trial is testingMulticenter, Open-Label, Randomised, Haloperidol-controlled Study to Evaluate Seroquel as Mono-Therapy in the Treatment of Agitated Symptoms in the Patients With Acute Episode of SchizophreniaWho this might be right forSchizophrenia Peking University 80
Post-approval studies (Phase 4)Study completedNCT01050478What this trial is testingIMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute AgitationWho this might be right forPsychomotor AgitationAcute Disease Janssen Cilag N.V./S.A. 56
Large-scale testing (Phase 3)Study completedNCT00970281What this trial is testingOlanzapine in Patients With SchizophreniaWho this might be right forSchizophrenia Eli Lilly and Company 91